DDIT3 and non-Hodgkin lymphoma: Analysis of the annual incidence of herpes zoster revealed that the incidence rate also reached a plateau in the first two years after diagnosis of NHL with 178 patients (87.68%) in the R-CHOP/R-CEOP group and 134 patients (76.14%) in the CHOP/CEOP group (Fig. 3).